Unknown OBSERVATIONAL NCT02926742

Submassive Pulmonary Embolism Experience With EKOS (SPEEK)

Sponsor: EKOS Corporation

Conditions Mechanical Thrombolysis Pulmonary Embolism Thrombolysis Thrombolytic Therapy

Interventions EkoSonic Endovascular System

Updated 8 times since 2017 Last updated: Oct 5, 2016 Started: Feb 28, 2014 Primary completion: Feb 28, 2017 Completion: Feb 28, 2017

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02926742, this observational or N/A phase trial focuses on Mechanical Thrombolysis and Pulmonary Embolism and remains ongoing. Sponsored by EKOS Corporation, it has been updated 8 times since 2014, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

8 versions recorded

Sep 2024 — Present [monthly]

Unknown
Jul 2024 — Sep 2024 [monthly]

Unknown

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status
Nov 2018 — Jan 2021 [monthly]

Unknown Status

Status: Recruiting → Unknown Status
Jun 2018 — Nov 2018 [monthly]

Recruiting

▶ Show 3 earlier versions

Apr 2018 — Jun 2018 [monthly]

Recruiting

Phase: NA → None
Feb 2017 — Apr 2018 [monthly]

Recruiting NA
Jan 2017 — Feb 2017 [monthly]

Recruiting NA

First recorded

Feb 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

EKOS Corporation
Krishna Mannava, MD, FACS, RPVI

Data source: Fairfield Medical Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Lancaster, United States